Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia

被引:43
作者
Kim, Dae-Young [1 ]
Lee, Je-Hwan [1 ]
Lee, Jung-Hee [1 ]
Kim, Sung-Doo [1 ]
Lim, Sung-Nam [1 ]
Choi, Yunsuk [1 ]
Lee, Young-Shin [1 ]
Kang, Young-Ah [1 ]
Seol, Miee [1 ]
Jeon, Mijin [1 ]
Kim, Joo Youn [1 ]
Lee, Kyung-Hwa [1 ]
Lee, Yeon-Joo [1 ]
Lee, Kyoo-Hyung [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul 138736, South Korea
关键词
Acute promyelocytic leukemia; Bleeding; ATRA; Fibrinogen; D-dimer; LDH; TRANS-RETINOIC ACID; REMISSION INDUCTION; THERAPY; CHEMOTHERAPY; ATRA;
D O I
10.1016/j.leukres.2010.05.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study was performed to determine whether any clinical parameters measured at diagnosis or during treatment are associated with bleeding in patients with acute promyelocytic leukemia (APL). Ninety patients with APL who were treated with all-transretinoic acid (ATRA) and anthracycline-based chemotherapy were analyzed. There were 24 significant bleeding events, classified by onset as 'hyperacute' (n = 5), 'acute' (n = 11) and 'late' (n = 8). Fifteen patients (17%) died because of bleeding. A poor fibrinogen (FBG) response during ATRA and chemotherapy was associated with an increased risk of bleeding (p = 0.003). Increased LDH and decreased FBG levels were associated with an increased incidence of bleeding, and low PLT count was correlated with death from bleeding. Our findings suggest that LDH/FBG levels and FBG response may be associated with morbidity and mortality from bleeding in patients with APL. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 27 条
[1]   Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up [J].
Avvisati, G ;
Petti, MC ;
Lo-Coco, F ;
Vegna, ML ;
Amadori, S ;
Baccarani, M ;
Cantore, N ;
Di Bona, E ;
Ferrara, F ;
Fioritoni, G ;
Gallo, E ;
Invernizzi, R ;
Lazzarino, M ;
Liso, V ;
Mariani, G ;
Ricciuti, F ;
Selleri, C ;
Sica, S ;
Veneri, D ;
Mandelli, F .
BLOOD, 2002, 100 (09) :3141-3146
[2]   Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial [J].
Burnett, AK ;
Grimwade, D ;
Solomon, E ;
Wheatley, K ;
Goldstone, AH .
BLOOD, 1999, 93 (12) :4131-4143
[3]  
CORDONNIER C, 1985, CANCER-AM CANCER SOC, V55, P18, DOI 10.1002/1097-0142(19850101)55:1<18::AID-CNCR2820550104>3.0.CO
[4]  
2-B
[5]   Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin [J].
de la Serna, Javier ;
Montesinos, Pau ;
Vellenga, Edo ;
Rayon, Chelo ;
Parody, Ricardo ;
Leon, Angel ;
Esteve, Jordi ;
Bergua, Juan M. ;
Milone, Gustavo ;
Deben, Guillermo ;
Rivas, Concha ;
Gonzalez, Marcos ;
Tormo, Mar ;
Diaz-Mediavilla, Joaquin ;
Gonzalez, Jose D. ;
Negri, Silvia ;
Amutio, Elena ;
Brunet, Salut ;
Lowenberg, Bob ;
Sanz, Miguel A. .
BLOOD, 2008, 111 (07) :3395-3402
[6]   Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia [J].
Di Bona, E ;
Avvisati, G ;
Castaman, G ;
Vegna, ML ;
De Sanctis, V ;
Rodeghiero, F ;
Mandelli, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) :689-695
[7]  
DOMBRET H, 1992, LEUKEMIA, V6, P1237
[8]  
DOMBRET H, 1993, LEUKEMIA, V7, P2
[9]   A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia [J].
Fenaux, P ;
Chastang, C ;
Chevret, S ;
Sanz, M ;
Dombret, H ;
Archimbaud, E ;
Fey, M ;
Rayon, C ;
Huguet, F ;
Sotto, JJ ;
Gardin, C ;
Makhoul, PC ;
Travade, P ;
Solary, E ;
Fegueux, N ;
Bordessoule, D ;
San Miguel, J ;
Link, H ;
Desablens, B ;
Stamatoullas, A ;
Deconinck, E ;
Maloisel, F ;
Castaigne, S ;
Preudhomme, C ;
Degos, L .
BLOOD, 1999, 94 (04) :1192-1200
[10]   BENEFICIAL EFFECT OF HEPARIN IN THE MANAGEMENT OF PATIENTS WITH APL [J].
HOYLE, CF ;
SWIRSKY, DM ;
FREEDMAN, L ;
HAYHOE, FGJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (03) :283-289